TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults
HIV-patients have excess of pneumococcal infection. We immunized 40 HIV-patients twice with pneumococcal conjugate vaccine (Prevnar, Pfizer) +/− a TLR9 agonist (CPG 7909). Peripheral blood mononuclear cells were stimulated with pneumococcal polysaccharides and cytokine concentrations measured. The C...
-д хадгалсан:
Үндсэн зохиолчид: | Rasmus Offersen (Зохиогч), Jesper Melchjorsen (Зохиогч), Søren R. Paludan (Зохиогч), Lars Østergaard (Зохиогч), Martin Tolstrup (Зохиогч), Ole S. Søgaard (Зохиогч) |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Taylor & Francis Group,
2012-08-01T00:00:00Z.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Immune checkpoints and the HIV-1 reservoir: proceed with caution
-н: Rikke Olesen, зэрэг
Хэвлэсэн: (2016) -
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
-н: Marina Luchner, зэрэг
Хэвлэсэн: (2021) -
Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia
-н: Vesa Lindström, зэрэг
Хэвлэсэн: (2018) -
Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures
-н: Juliette Fortpied, зэрэг
Хэвлэсэн: (2018) -
Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
-н: Jesper D. Gunst, зэрэг
Хэвлэсэн: (2019)